Bicarbonate and bicarbonate/lactate peritoneal dialysis solutions for the treatment of infusion pain

Kidney International
R A MactierD Faict

Abstract

A randomized, double-blind, cross-over study was undertaken to determine the effects of novel bicarbonate (38 mM) and bicarbonate (25 mM)/lactate (15 mM) containing peritoneal dialysis (PD) solutions on infusion pain in patients who experienced inflow pain with conventional lactate (40 mM) solution. Pain was assessed using a verbal rating scale and the validated McGill Pain Questionnaire (MPQ). Eighteen patients were recruited to the study. Both novel solutions resulted in highly statistically significant reductions in inflow pain compared to the control lactate solution, as assessed with both the verbal rating scale and the MPQ. For all pain variables assessed, the bicarbonate/lactate solution was more effective than the bicarbonate solution in alleviating pain. In conclusion, both solutions reduced the infusion pain experienced with control solution, but the bicarbonate/lactate solution appears to be the most effective. In contrast to the most widespread current treatment, which is the manual injection of sodium bicarbonate, the bicarbonate/lactate solution does not have the associated increased risk of peritonitis.

References

Jan 1, 1978·Scandinavian Journal of Urology and Nephrology·P Thayssen, T Pindborg
Dec 11, 1975·Journal of Chronic Diseases·C A VaamondeK E Carroll
Jan 1, 1985·Nephron·F B PedersenP Kildeberg
Jun 1, 1982·Kidney International·Y M BinikL McMullen
Jul 5, 2007·Journal of Lipid Research·Barbara P AtshavesFriedhelm Schroeder

❮ Previous
Next ❯

Citations

Dec 20, 2003·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Vladimirs StrazdinsUNKNOWN European Pediatric Peritoneal Sialysis Working Group
Sep 25, 2007·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Ramesh Saxena
Mar 31, 2011·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Claus Peter SchmittUNKNOWN European Pediatric Dialysis Working Group
Sep 28, 2006·International Urology and Nephrology·Mufazzal AhmadDimitrios G Oreopoulos
Oct 25, 2007·Nature Clinical Practice. Nephrology·Pieter M ter Wee, Frans J van Ittersum
Dec 12, 2001·Kidney International·Z H ZhengB Lindholm
Nov 20, 2002·Seminars in Dialysis·Dominic S C Raj
May 20, 2003·Artificial Organs·W Van BiesenN Lameire
Mar 20, 2004·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Michel FischbachBörje Haraldsson
Mar 20, 2004·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Cornelis H Schröder
Jun 24, 2004·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Andreas FusshoellerJoerg Plum
Jun 23, 2010·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Johan V PovlsenIra D Davis
May 13, 2011·Nephron. Clinical Practice·Graham Woodrow, Simon Davies
May 30, 2012·Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis·David W JohnsonFiona G Brown
Sep 20, 2012·Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis·Peter G Blake
Jan 26, 2013·Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis·Bengt Rippe
Dec 20, 2012·International Journal of Nephrology·Yeoungjee ChoDavid W Johnson
Jul 16, 2005·The American Journal of the Medical Sciences·Ramesh Saxena
Mar 22, 2001·Kidney International·S JonesUNKNOWN Bicarbonate/Lactate Study Group
Feb 15, 2007·Kidney International·C W McIntyre
Jan 1, 2008·Kidney International·F Locatelli, V La Milia
Jun 18, 2004·Kidney International·John D WilliamsUNKNOWN Euro Balance Trial Group
Feb 12, 2004·Kidney International. Supplement·Roberto Pecoits-FilhoBengt Lindholm
Jun 30, 2000·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·D S RajJ Work
Feb 26, 2013·Seminars in Dialysis·Samir S Patel
May 5, 2010·Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·Charles J Diskin
Aug 6, 2013·European Journal of Pharmacology·Gabriela TrevisanJuliano Ferreira
Aug 4, 2015·BioMed Research International·Krzysztof PawlaczykAndrzej Breborowicz
Oct 27, 2001·Seminars in Dialysis·J Passlick-DeetjenA Jörres
Aug 3, 2000·Seminars in Dialysis·M Feriani
Feb 6, 2017·Seminars in Nephrology·Cheuk Chun Szeto, David W Johnson
Nov 10, 2000·Advances in Renal Replacement Therapy·R Gokal
Sep 5, 2001·Advances in Renal Replacement Therapy·A Jörres
Nov 18, 2017·BMC Nephrology·Graham WoodrowAndrew Neil Pyrah
Mar 29, 2014·The Cochrane Database of Systematic Reviews·Yeoungjee ChoKathryn J Wiggins
Jun 22, 2018·Clinical and Experimental Nephrology·Bart DioosAnders P Wieslander
Jan 23, 2010·Clinical Journal of the American Society of Nephrology : CJASN·Kunal Chaudhary, Ramesh Khanna
Jul 6, 2014·Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis·Peter Blake
Jan 1, 2014·Current Opinion in Nephrology and Hypertension·Yeoungjee Cho, David W Johnson
Mar 3, 2017·Seminars in Dialysis·Paraish S MisraJeffrey Perl
Oct 27, 2018·The Cochrane Database of Systematic Reviews·Htay HtayYeoungjee Cho
Apr 11, 2020·Seminars in Dialysis·Megha Salani, Thomas Golper

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.